EUROLAB
usp-1078-good-manufacturing-practices-for-impurity-reduction
Impurity Profiling EMA Guideline on Genotoxic Impurities in PharmaceuticalsEMA Reflection Paper on Low Level ImpuritiesFDA Guidance: Microbial Impurities and Endotoxin LevelsFDA Guidance: Threshold of Toxicological Concern (TTC) for ImpuritiesFDA ICH M3(R2): Impurities in Safety StudiesFDA Q&A on Impurities in Generic Drug ApplicationsFDA Q&A: Managing Impurities in Complex APIsICH E14: QT Interval Evaluation and Impurity ImpactICH M7: Mutagenic Impurity Risk AssessmentICH Q10: Pharmaceutical Quality System for Impurity ManagementICH Q11: Impurity Control Strategy in Drug Substance DevelopmentICH Q12: Lifecycle Management of Impurity Control StrategyICH Q1E: Evaluation of Stability Data Related to Impurity FormationICH Q2(R1): Validation of Analytical Methods for Impurity TestingICH Q3A: Organic Impurity Profiling in Drug SubstancesICH Q3B: Impurity Testing in Finished Drug ProductsICH Q3C: Residual Solvent ProfilingICH Q3D: Elemental Impurity Risk AssessmentICH Q3F: Impurity Guidelines for Biotechnology ProductsICH Q4B: Harmonization of Analytical Procedures for Impurity TestingICH Q5C: Impurity Monitoring in Biotechnological ProductsICH Q6A: Specifications and Acceptance Criteria for ImpuritiesICH S3A: Impurities Arising from Degradation ProductsICH S6: Biotech Product Impurity ProfilingICH S7A: Safety Pharmacology Impurity EvaluationICH S9: Impurities in Oncology ProductsISO 10993-18: Chemical Characterization and Impurity AnalysisISO 17025: Accreditation for Impurity Testing LaboratoriesJP General Rule 2.60: Limit Test for ImpuritiesPh. Eur. 2.2.28: Gas Chromatography for Impurity DetectionPh. Eur. 2.2.38: Thin-Layer Chromatography for ImpuritiesPh. Eur. 2.2.46: Chromatographic Separation for Impurity AnalysisPh. Eur. 2.4.14: Determination of Inorganic ImpuritiesPh. Eur. 2.4.20: Limit Test for Heavy Metals in ImpuritiesPh. Eur. 2.4.24: Related Substances by HPLC in APIsPh. Eur. 2.4.29: Limit Test for Sulfated Ash ImpuritiesPh. Eur. 2.5.13: Oxidizing Impurity TestsPh. Eur. 2.9.40: Uniformity of Dosage Units and Related ImpuritiesPh. Eur. 5.10: Control of Impurities in Substances for Pharmaceutical UsePh. Eur. 5.4: Impurities in Radiopharmaceutical PreparationsUSP <1010>: Analytical Data Integrity in Impurity ReportingUSP <1031>: The Biocompatibility of Materials and ImpuritiesUSP <1051>: Cleaning Validation Limits and Residual ImpuritiesUSP <1058>: Analytical Instrument Qualification for Impurity StudiesUSP <1085>: Evaluation of Impurity Method PerformanceUSP <1086>: Impurities in Drug SubstancesUSP <1088>: Forced Degradation Studies for Impurity CharacterizationUSP <1091>: Impurity Isolation and Characterization TechniquesUSP <1099>: Acceptable Analytical Performance CriteriaUSP <1121>: Bulk Pharmaceutical Chemicals and Impurity HandlingUSP <1151>: Pharmaceutical Dosage Forms and Impurity ConsiderationUSP <1191>: Stability Testing of Compounded PreparationsUSP <1222>: Terminal Sterilization Impact on ImpuritiesUSP <1224>: Transfer of Impurity Test ProceduresUSP <1225>: Validation of Compendial Procedures for ImpuritiesUSP <1226>: Verification of Compendial Procedures for Impurity DetectionUSP <1231>: Water for Pharmaceutical Purposes and Impurity EffectsUSP <1232>: Water Activity and Impurity StabilityUSP <1241>: Capsules and Shell Impurity InteractionUSP <1251>: Weighing on Analytical Balances for Micro-ImpuritiesUSP <161>: Transdermal Delivery Systems and Impurity ControlUSP <197>: Spectrophotometric Identification of ImpuritiesUSP <233>: Elemental Impurities Profiling Using ICP-MSUSP <41>: Balances Used for Impurity Weight DeterminationUSP <466>: Identification and Quantification of DegradantsUSP <467>: Residual Solvent Testing in APIs and ExcipientsUSP <476>: Impurity Profiling for New Drug ApplicationsUSP <621>: Chromatography Conditions for Impurity IdentificationUSP <730>: Plasma Spectrochemistry for Impurity ProfilingUSP <791>: pH Determination Impact on Impurity SolubilityUSP <797>: Sterile Compounding and Impurity ControlUSP <800>: Hazardous Drug Handling Based on Impurity RiskUSP <851>: Spectrophotometry and Light Scattering for ImpuritiesUSP <853>: Atomic Absorption Spectroscopy for Trace ImpuritiesUSP <857>: UV-Vis Spectroscopy for Impurity QuantificationUSP <85>: Bacterial Endotoxin Limits Related to Impurity SafetyUSP <891>: Nuclear Magnetic Resonance (NMR) for Structural ElucidationUSP <905>: Content Uniformity Related to ImpuritiesUSP <905>: Uniformity of Dosage Units Affected by ImpuritiesUSP <941>: Characterization of Impurity Solubility and pKaWHO TRS 970 Annex 2: Impurity Control in Medicines

USP <1078>: Good Manufacturing Practices for Impurity Reduction - EUROLABs Laboratory Testing Service

The USP <1078> standard is a crucial guideline for ensuring the quality and purity of pharmaceutical products. It provides a framework for manufacturers to follow in order to minimize impurities and ensure compliance with regulatory requirements. This section will provide an overview of the relevant standards, legal and regulatory framework, international and national standards, and standard development organizations.

Relevant Standards:

The USP <1078> standard is based on the following ISO standards:

  • ISO 9001:2015 (Quality Management System)
  • ISO/IEC 17025:2017 (General Requirements for Competence of Testing and Calibration Laboratories)
  • Additionally, the EUROLAB laboratory testing service also complies with other relevant national and international standards, including:

  • EN 14644-1 (Cleanrooms and Associated Controlled Environments - Part 1: Classification of Air Cleanliness)
  • TSE 1485 (Pharmaceuticals - Good Manufacturing Practices for Active Pharmaceutical Ingredients)
  • Legal and Regulatory Framework:

    The USP <1078> standard is governed by the following regulatory bodies:

  • US Food and Drug Administration (FDA)
  • European Medicines Agency (EMA)
  • World Health Organization (WHO)
  • Manufacturers must comply with these regulations to ensure that their products meet the required standards.

    International and National Standards:

    The following international and national standards apply to this specific laboratory test:

  • ISO 17025:2017
  • EN 14644-1
  • TSE 1485
  • These standards outline the requirements for testing laboratories, including equipment, personnel, and quality control measures.

    Standard Development Organizations:

    The USP <1078> standard is developed by the following organizations:

  • United States Pharmacopeia (USP)
  • International Organization for Standardization (ISO)
  • These organizations ensure that the standard remains up-to-date and reflects current best practices in laboratory testing.

    Why This Test is Needed:

    Manufacturers must conduct USP <1078> testing to ensure that their products meet the required standards of purity and quality. Failure to do so can result in product recalls, fines, and damage to reputation.

    The consequences of not performing this test include:

  • Product contamination
  • Inadequate quality control measures
  • Regulatory non-compliance
  • This section will explain in detail why USP <1078> testing is necessary and required.

    This section will provide an overview of the business and technical reasons for conducting USP <1078>: Good Manufacturing Practices for Impurity Reduction testing. It will also outline the industries and sectors that require this testing, risk factors, safety implications, quality assurance and control aspects, product safety and reliability contributions, competitive advantages, cost-benefit analysis, and other relevant information.

    Business Reasons:

    The main business reasons for conducting USP <1078> testing include:

  • Ensuring compliance with regulatory requirements
  • Maintaining a high level of quality and purity in products
  • Avoiding product recalls and fines
  • Protecting reputation and brand image
  • Technical Reasons:

    The main technical reasons for conducting USP <1078> testing include:

  • Minimizing impurities and contaminants
  • Ensuring accurate and precise testing results
  • Developing a robust quality control system
  • Industries and Sectors:

    This test is required by the following industries and sectors:

  • Pharmaceutical manufacturers
  • Biotechnology companies
  • Food and beverage producers
  • Cosmetics and personal care manufacturers
  • These industries require high-quality products to ensure consumer safety and satisfaction.

    Risk Factors and Safety Implications:

    The main risk factors associated with USP <1078> testing include:

  • Product contamination
  • Inadequate quality control measures
  • Regulatory non-compliance
  • Failure to address these risks can result in product recalls, fines, and damage to reputation.

    Quality Assurance and Control Aspects:

    This test contributes to product safety and reliability by ensuring that manufacturers follow good manufacturing practices. It also helps manufacturers develop a robust quality control system.

    Competitive Advantages:

    Manufacturers who conduct USP <1078> testing can enjoy several competitive advantages, including:

  • Improved product quality
  • Enhanced brand image
  • Increased customer confidence
  • Cost-Benefit Analysis:

    The cost-benefit analysis of performing USP <1078> testing includes:

  • Reduced costs associated with product recalls and fines
  • Improved reputation and brand image
  • Enhanced customer satisfaction
  • This section will provide a detailed explanation of the benefits and advantages of conducting USP <1078>: Good Manufacturing Practices for Impurity Reduction testing.

    This section will provide a step-by-step guide to conducting USP <1078> testing, including equipment and instruments used, personnel required, quality control measures, and other relevant information.

    Equipment and Instruments:

    The following equipment and instruments are required for this test:

  • High-performance liquid chromatography (HPLC) system
  • Mass spectrometry system
  • Gas chromatography-mass spectrometry (GC-MS) system
  • These systems ensure accurate and precise testing results.

    Personnel Required:

    This test requires highly trained and experienced personnel, including:

  • Laboratory technicians
  • Chemists
  • Quality control specialists
  • These personnel ensure that the test is conducted accurately and efficiently.

    Quality Control Measures:

    This test follows a robust quality control system, which includes:

  • Calibration of equipment
  • Validation of methods
  • Regular maintenance and calibration of instruments
  • These measures ensure that the test results are reliable and accurate.

    Other Relevant Information:

    This section will provide additional information on conducting USP <1078> testing, including:

  • Sampling procedures
  • Data analysis
  • Reporting requirements
  • Manufacturers must follow these guidelines to ensure compliance with regulatory requirements.

    Conclusion:

    USP <1078> testing is a critical component of good manufacturing practices for pharmaceutical manufacturers. This guide has provided an overview of the relevant standards, legal and regulatory framework, international and national standards, standard development organizations, business reasons, technical reasons, industries and sectors, risk factors and safety implications, quality assurance and control aspects, competitive advantages, cost-benefit analysis, equipment and instruments required, personnel needed, quality control measures, and other relevant information. Manufacturers must conduct this test to ensure compliance with regulatory requirements and maintain a high level of product quality.

    EUROLABs Laboratory Testing Service:

    EUROLAB is a leading laboratory testing service provider that offers USP <1078> testing for pharmaceutical manufacturers. Our state-of-the-art facilities, highly trained personnel, and robust quality control system ensure accurate and precise testing results. We provide customized solutions to meet the specific needs of our clients.

    Contact Us:

    For more information on EUROLABs laboratory testing service or to schedule a test, please contact us at:

    Email: infoeurolab.com(mailto:infoeurolab.com)

    Phone: 1-800-EUROLAB

    Address: 123 Main St, Anytown, USA

    We look forward to serving your testing needs.

    Need help or have a question?
    Contact us for prompt assistance and solutions.

    Latest News

    View all

    JOIN US
    Want to make a difference?

    Careers